by last | Jul 6, 2022 | 2022, Past Events
Philogen announces its attendance at the Peptide Therapeutic Forum 2022. Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a lecture entitled “Small Molecule Therapeutics as an alternative to Peptide Therapeutics: a clean strategy to...by last | Jul 6, 2022 | 2022, Past Events
Dr. Ettore Gilardoni, Head of Bio-MS at Philogen, will present a poster entitled: A mass spectrometry-based method for the determination of in vivo biodistribution of small molecule-metal conjugates. Dr. Gilardoni will also give a presentation on August 31st,...by last | Jun 27, 2022 | 2022, Past Events
Philogen will be Bronze Sponsor of the Post-Chicago Meeting in Münich (30-1 July). Philogen will chair a Satellite Symposium on Friday July 1, 11.30-12.00 am. Dr. Alfredo Covelli, Philogen’s CMO, will give a presentation entitled “Immunocytokines for the therapy...by last | Jun 27, 2022 | 2022, Past Events
Philogen will attend the 13th World ADC in San Diego (USA) in September 2022. Samuele Cazzamalli, Head of Small Molecules Therapeutics at Philogen, will give a lecture in person entitled “Pan-Tumoral Small Molecule-Drug Conjugates Targeting Fibroblasts Activation...by last | Jun 27, 2022 | 2022, Past Events
Philogen attends ESMO in September 2022. Tobias Weiss, MD/PhD, Neuro-Oncologist at the Universitätsspital Zürich, to give a presentation entitled “The combination of lomustine and antibody-based targeted TNF (L19TNF) as a promising treatment for recurrent...